ORN Webinar Fall 2021 #5 - Treating Opioid Use Disorder in Pregnancy and the Perinatal Period
Recorded On: 09/15/2021
(Part 1) ORN Webinar Series: A two-part, one hour each, webinar on treating opioid use disorder in pregnancy and the perinatal period. This lecture will discuss care of pregnant and postpartum people with Opioid Use Disorder and their families and discuss and debunk common myths and misperceptions. The second hour will be devoted to Q&A. Case studies may be included in the Q&A session to advance ones knowledge on the topic.
If you have not registered for one of our webinars in the past, please subscribe to AOAAM, then login and register for the webinars.
Goals & Objectives:
- Review limitations and biases in presenting existing national prevalence data in perinatal opioid use
- Describe treatment considerations for women with OUD during pregnancy Explore the unique stigma and discrimination surrounding pregnancy and SUD treatment
- Identify opportunities for improved engagement, care, and collaboration in preparation for delivery.
- Discuss the unique risks to substance-exposed families in the early postpartum period, including recurrence of substance use
This webinar series has been approved for a maximum 6, AOA Category 1-A CME credits, and AOA designates this for a maximum of 6, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.
Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Davida Schiff, MD
MassGeneral for Children
Dr. Schiff is a general academic pediatrician and health services researcher focused on understanding how substance use in pregnant and parenting women impacts the health of children and families. She is the Medical Director of the HOPE Clinic (Harnessing support for Opioid and substance use disorder in Pregnancy and Early childhood) at Massachusetts General Hospital, a multidisciplinary program caring for women and families with substance use disorder from the time of conception through the first two years postpartum.
Dr. Schiff completed her undergraduate training at Columbia University, medical training at the Boston University School of Medicine, pediatrics residency in the Boston Combined Residency Program at Boston Medical Center and Boston Children’s Hospital, general pediatrics research fellowship at Boston Medical Center, and master’s program in health services research from the Boston University School of Public Health. Her research is focused on improving care for families affected by substance use and her past scholarship has been published in the New England Journal of Medicine, JAMA, Pediatrics, Academic Pediatrics, Journal of Substance Abuse and Treatment, and Substance Abuse, among other journals. She is an Assistant Professor of pediatrics at Harvard Medical School.
Julie Kmiec, DO, FAOAAM (Moderator)
AOAAM Past President
Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program.
Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.